Breast Cancer Treatment side effects
Breast Cancer Treatment: AI Tool Predicts Side Effect Risks

An artificial intelligence (AI) tool created by a group of international researchers can identify breast.

Synthetic Biology: Enhancing Nutritional Value, Color, and Flavor
Synthetic Biology: Enhancing Nutritional Value, Color, and Flavor

In a recent publication featured in Nature Communications, scholars have devised a modular synthetic biology.

Exploring the risks and benefits of OTC medications for COVID-19
COVID-19 Over-the-Counter Medication Considerations

The COVID-19 virus can cause symptoms including weariness, fever, coughing, and sore throat. The most.

Liver
FDA Approves Rezdiffra Drug to Treat Liver Disease

Rezdiffra (resmetirom) was approved today by the United States Food and Drug Administration for the.

Culinary Herbs and Spices with Polyphenols - Enhancing Gut Health
Culinary Herbs and Spices with Polyphenols – Enhancing Gut Health

In a recent publication in the journal Nutrients, a team of researchers delved into the.

Tandem Cycling Enhances Well-Being for Parkinson's Patients and Care Partners
Tandem Cycling Enhances Well-Being for Parkinson’s Patients and Care Partners

Tandem cycling holds the promise of enhancing the health and overall well-being of both individuals.

Bariatric Surgery is an effective tool for achieving Type 2 diabetes control
Bariatric surgery is an Effective Tool for Managing Diabetes

Bariatric surgery is more beneficial than medicine and lifestyle changes in achieving long-term Type 2.

allergy-triggering foods
Drug can Reduce Harmful Reactions to Foods causing Allergy

A medication can make life safer for children with food allergies by preventing deadly allergic.

Omalizumab
FDA approves omalizumab for food allergy reactions based on NIH research

Moment‘s Food and Drug Administration blessing of a supplemental biologics license for the monoclonal antibody omalizumab( Xolair) highlights the vital part of the National Institutes of.

FDA Approves the First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma
FDA Approves First Cellular Therapy for Skin Cancer Patients

Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type.